Event & Action Board

Dry Eye Syndrome (DES) is a chronic condition affecting millions, often caused by an imbalance in the tear film. Absorbable punctum plugs represent a minimally invasive, temporary therapeutic intervention used to manage this condition. These tiny devices are inserted into the puncta—the small openings in the eyelids through which tears drain—to block drainage and keep the eye's natural moisture on the surface for a longer duration.

The primary advantage of the absorbable variety, typically made of materials like collagen or synthetic polymers, is their temporary nature. They are designed to dissolve within a specific timeframe, ranging from a few days to several months. This allows clinicians to perform a "trial run" to see if permanent occlusion would be beneficial for the patient without committing to a long-term procedure. It is an essential diagnostic and therapeutic bridge in ophthalmic care.

From a patient perspective, the insertion is quick and generally painless. By increasing the volume of the tear film, these plugs alleviate symptoms such as grittiness, redness, and blurred vision. As digital device usage increases—which often leads to reduced blink rates and exacerbated dry eye—the relevance of punctal occlusion as a frontline treatment continues to grow, offering a biocompatible solution to ocular discomfort.